Role of EZH2 Polymorphisms in Esophageal Squamous Cell Carcinoma Risk in Han Chinese Population

Association between EZH2 polymorphisms and colorectal cancer risk in Han Chinese population

(2014) Jian Wang et al.   MEDICAL ONCOLOGY

Association of a Genetic Variation in a miR-191 Binding Site in MDM4 with Risk of Esophageal Squamous Cell Carcinoma

(2013) Liqing Zhou et al.   PLoS One

EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle

(2012) L. Fornaro et al.   ANNALS OF ONCOLOGY

Polymorphisms in the ERCC5 Gene and Risk of Esophageal Squamous Cell Carcinoma (ESCC) in Eastern Chinese Populations

(2012) Mei-Ling Zhu et al.   PLoS One

An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients

(2011) F. Crea et al.   ANNALS OF ONCOLOGY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy

(2010) W. Zhang et al.   ANNALS OF ONCOLOGY

Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer

(2010) S. M. Lipkin et al.   Cancer Prevention Research

Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer

(2010) Kyong-Ah Yoon et al.   Journal of Thoracic Oncology

Epigenetic gene regulation in stem cells and correlation to cancer

(2009) Lesley A. Mathews et al.   DIFFERENTIATION

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

(2009) Li-Ru He et al.   INTERNATIONAL JOURNAL OF CANCER

Intron-1 rs3761548 is related to the defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding

(2008) Z. Shen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Over-expression of polycomb group protein EZH2 relates to decreased expression of p16INK4a in cholangiocarcinogenesis in hepatolithiasis

(2008) M Sasaki et al.   JOURNAL OF PATHOLOGY

Roles of the EZH2 histone methyltransferase in cancer epigenetics

(2008) Jeffrey A. Simon et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

(2008) Kazunori Kidani et al.   ORAL ONCOLOGY